1. Home
  2. ENLV vs SYNX Comparison

ENLV vs SYNX Comparison

Compare ENLV & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENLV
  • SYNX
  • Stock Information
  • Founded
  • ENLV 2005
  • SYNX 2005
  • Country
  • ENLV Israel
  • SYNX Israel
  • Employees
  • ENLV N/A
  • SYNX N/A
  • Industry
  • ENLV Biotechnology: Pharmaceutical Preparations
  • SYNX
  • Sector
  • ENLV Health Care
  • SYNX
  • Exchange
  • ENLV Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • ENLV 23.7M
  • SYNX 20.8M
  • IPO Year
  • ENLV 1995
  • SYNX 2024
  • Fundamental
  • Price
  • ENLV $1.19
  • SYNX $3.76
  • Analyst Decision
  • ENLV Strong Buy
  • SYNX
  • Analyst Count
  • ENLV 2
  • SYNX 0
  • Target Price
  • ENLV $9.50
  • SYNX N/A
  • AVG Volume (30 Days)
  • ENLV 206.7K
  • SYNX 2.9K
  • Earning Date
  • ENLV 03-28-2025
  • SYNX 10-02-2024
  • Dividend Yield
  • ENLV N/A
  • SYNX N/A
  • EPS Growth
  • ENLV N/A
  • SYNX N/A
  • EPS
  • ENLV N/A
  • SYNX N/A
  • Revenue
  • ENLV N/A
  • SYNX $9,893,000.00
  • Revenue This Year
  • ENLV N/A
  • SYNX $52.34
  • Revenue Next Year
  • ENLV N/A
  • SYNX N/A
  • P/E Ratio
  • ENLV N/A
  • SYNX N/A
  • Revenue Growth
  • ENLV N/A
  • SYNX 18.05
  • 52 Week Low
  • ENLV $0.81
  • SYNX $2.10
  • 52 Week High
  • ENLV $4.59
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • ENLV 59.22
  • SYNX 44.90
  • Support Level
  • ENLV $1.04
  • SYNX $3.72
  • Resistance Level
  • ENLV $1.17
  • SYNX $3.99
  • Average True Range (ATR)
  • ENLV 0.10
  • SYNX 0.13
  • MACD
  • ENLV 0.02
  • SYNX -0.01
  • Stochastic Oscillator
  • ENLV 71.51
  • SYNX 36.33

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: